Stephanie Kennan on Food and Drug Administration (FDA)

Washington Healthcare Update - February 2020 #2

This week in Washington: Senate to hold hearing on home healthcare in rural America, House to hold hearing on protecting women's access to reproductive healthcare....more

2/11/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Part D , Opioid , Prescription Drugs , Trump Administration

Washington Healthcare Update - February 2020 #1

This week in Washington: The House of Representatives passes legislation on fentanyl analogues; Senate continues impeachment trial....more

2/4/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Advantage , Trump Administration

Washington Healthcare Update - January 2020 #4

This week in Washington: Both the House and Senate are back in session....more

1/28/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Generic Drugs , Health Insurance Portability and Accountability Act (HIPAA) , Medicaid , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - January 2020 #3

This week in Washington: The House is not in session. The Senate will resume the impeachment trial on Tuesday....more

1/22/2020 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , MACPAC , Medicare , Medicare Advantage , Pharmaceutical Industry , Trump Administration , United States-Mexico-Canada Agreement (USMCA)

House Energy and Commerce Committee Subcommittee on Health: Cannabis Policies for the New Decade

On Jan. 15, the Subcommittee on Health of the Committee on Energy and Commerce held a legislative hearing to discuss cannabis policy. The focal point of most of the hearing was about research into marijuana, its extracts and...more

1/20/2020 / Controlled Substances Act , Food and Drug Administration (FDA) , Marijuana , Medical Marijuana

Courts and Healthcare Policy in 2020

2019 saw court hearings of a number of cases related to the Affordable Care Act (ACA). Several other Trump administration policies were also challenged, including Medicare payment policies, price transparency, how the...more

1/15/2020 / Affordable Care Act , Association Health Plans , Centers for Medicare & Medicaid Services (CMS) , Contraceptive Coverage Mandate , Cost-Sharing , Drug Pricing , Food and Drug Administration (FDA) , Hospitals , Medicaid , Section 340B , Trump Administration

Washington Healthcare Update - January 2020 #2

Tuesday, January 14, 2020 - House Committee on Energy and Commerce: “A Public Health Emergency: State Efforts to Curb the Opioid Crisis” - The Subcommittee on Oversight and Investigations of the Committee on Energy and...more

1/14/2020 / Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , HRSA , MACPAC

Washington Healthcare Update - January 2020 #1

Wednesday, Jan. 8, 2020 - House Committee on Energy and Commerce: “Legislation to Improve Americans’ Health Care Coverage and Outcomes” - The Subcommittee on Health of the Committee on Energy and Commerce will hold a...more

1/7/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - December 2019 #3

This Week in Washington: The House and Senate are out of session until the new year. Congress - House - House Passes USMCA Trade Deal ...more

12/24/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Impeachment , Individual Mandate , OIG , Outpatient Prospective Payment System (OPPS) , Trump Administration , United States-Mexico-Canada Agreement (USMCA)

Washington Healthcare Update - December 2019 #2

This Week in Washington: The House and Senate will leave for the holidays by Dec. 20....more

12/17/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Care Providers , Hospitals , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - December 2019 #1

This Week in Washington: The House and Senate are back from Thanksgiving recess. Congress is expected to be in session until or about Dec. 20....more

12/10/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Hospitals , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs , Safe Harbors , Stark Law , Trump Administration

Washington Healthcare Update - November 2019 #4

This week in Washington: The House and Senate are out for Thanksgiving recess this week. Congress - Hearings/Markups - House Committee on the Judiciary: “The Patent Trial and Appeal Board and the Appointments Clause:...more

11/26/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Draft Guidance , Food and Drug Administration (FDA) , GAO , OIG , Outpatient Prospective Payment System (OPPS) , Prescription Drugs , Transparency

Washington Healthcare Update - November 2019 #3

This week in Washington: Senate to hold a confirmation hearing for Dr. Stephen Hahn, Trump's nominee to be the new FDA commissioner, as well as a hearing on Alzheimer's awareness. ...more

11/19/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Self-Referral , Stark Law

Washington Healthcare Update - November 2019 #2

This week in Washington: House returns from recess and has scheduled hearing on caring for aging Americans; Senate to hold hearing on rising electronic cigarette use among youth and will hold a confirmation hearing for Dr....more

11/12/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare Part B , OIG , Pharmaceutical Industry , Prescription Drugs , Safe Harbors , Self-Referral , Stark Law

Washington Healthcare Update - November 2019 #1

This week in Washington: Senate to hold a hearing on the response to lung illness and rising youth electronic cigarette use, as well as a hearing on protecting veterans from a variety of scams, including fake charities....more

11/5/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Medicaid , OIG , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs

Washington Healthcare Update - October 2019 #4

This week in Washington: Senate to hold a hearing on eligibility requirements under the Medicaid program, as well as a hearing to review a number of healthcare bills, including OTC drug safety, innovation and reform....more

10/29/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Care Providers , MACPAC , Medicare , OIG , Opioid , Pharmaceutical Industry , Physicians , Prescription Drugs , Self-Referral , Stark Law , Trump Administration

Washington Healthcare Update - October 2019 #2

This week in Washington: The House and Senate return tomorrow from a two-week-long recess. Upcoming Hearings/Markups - Congress - House - Blue Dog Democrats Urge Speaker Pelosi to Call Vote on Several Bipartisan...more

10/15/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Care Providers , Home Health Agencies , Hospitals , OIG , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Washington Healthcare Update - October 2019 #1

This week in Washington: The House and Senate are in recess. Congress House Senate Administration Proposed Regulations/Guidance Final Rules/Guidance Reports House Bipartisan Legislation Introduced on Accurate Provider...more

10/8/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Insurance Portability and Accountability Act (HIPAA) , Medical Devices , Medicare , OMB , Prescription Drugs , SAMHSA , Trump Administration

Washington Healthcare Update - September 2019 #4

This week in Washington: The House and Senate are in recess. Congress - Hearings/Markups - Senate Special Committee on Aging: “Promoting Healthy Aging – Living Your Best Life Long into Your Golden Years”...more

10/1/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Pharmaceutical Industry , Popular , Prescription Drugs , SAMHSA , Trump Administration

Washington Healthcare Update - September 2019 #3

This week in Washington: Hearings on the public health impact of e-cigarettes, making prescription drugs more affordable and promoting healthy aging. ...more

9/24/2019 / Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Employee Retirement Income Security Act (ERISA) , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Washington Healthcare Update - September 2019 #2

This week in Washington: Hearing on public health impact of e-cigarettes, meeting on continuing appropriations for fiscal year 2020, and hearing on how pharmaceutical companies game the system....more

9/17/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicaid , Mental Health , SAMHSA

Washington Healthcare Update - September 2019 #1

This week in Washington: Senate to markup the Labor, Health and Human Services, Education and Related Agencies Appropriations Act; House to hold hearings on improving maternal health and the Administration's apparent...more

9/10/2019 / Ambulatory Surgery Centers , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Insurance , IRS , Opioid , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , SAMHSA

Washington Healthcare Update - August 2019 #2

Congress - House - In Recess - Cummings and Sanders Seek Information About Possible Obstruction of a Congressional Investigation on Generic Drug Prices...more

8/20/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Generic Drugs , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - August 2019 #1

Congress - House - House Passes Short-Term Funding Extension for Medicaid Pilot Program - On July 30, the House passed a bill to keep a $1 billion Medicaid pilot providing mental health and addiction services running...more

8/6/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , Medicaid , Medicare , Opioid , Pharmaceutical Industry , Physicians , Prescription Drugs , Trump Administration

Washington Healthcare Update July 2019 #3

This week in Washington: The House is out for summer recess; Senate is in session until the end of this week....more

7/29/2019 / Biologics , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicaid , Mental Health , Pharmaceutical Industry , Prescription Drugs

Stephanie Kennan

McGuireWoods LLP

Readers' Choice Awards

Popular Topics by This Author

Latest Posts › Food and Drug Administration (FDA)